Protective Mechanisms Of MAP Kinase Phosphatase 5 In Adipose Tissue Fibrosis, Hepatic Steatosis And Atherosclerosis
Funder
National Health and Medical Research Council
Funding Amount
$352,729.00
Summary
Obesity and associated complications such as diabetes, non-alcoholic fatty liver disease and atherosclerosis are a serious health burden. Recently, we found that MKP5, a molecule that restricts intracellular signaling, plays a central role in preventing these diseases. This collaborative project will elucidate how precisely MKP5 acts and explore how this molecule can be targeted for the development of novel therapeutic strategies in prevention and treatment of human metabolic diseases.
Impact Of Exercise Intervention On The Phenome (Metabolism And Predictive Complications) In Well Characterised Prediabetes And New Onset Type 2 Diabetes Cohorts In China And Australia (TheDiabeEx.JointStudy).
Funder
National Health and Medical Research Council
Funding Amount
$567,323.00
Summary
This proposal will study people with prediabetes or a new diagnosis of type 2 diabetes, compared with a group with normal blood glucose, in China and in Australia. It will examine, in well defined cohorts: 1. the extent of traditional and more novel organ complications and metabolic markers early in the disease course; 2. in people with abnormal blood glucose, the potential benefits of an exercise regimen to their metabolic health, biomarkers and complications.
Role Of Sphingolipid Signalling In Hepatic Insulin Resistance And Its Application In Prediction Of Risk For Type 2 Diabetes And Prediabetes
Funder
National Health and Medical Research Council
Funding Amount
$563,305.00
Summary
Type 2 diabetes is expected to reach epidemic proportions in the coming decades. Prediabetes is usually unrecognized and constitutes a major public health concern that needs earlier interventions, because the majority of prediabetic subjects proceed to T2D. We have identified an enzyme that plays an important role in insulin signalling. The possibility is that the level or activity of this enzyme is a potential biomarker of the prediabetes state and could be also used as a target